Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Genetic risk for Alzheimer's disease is distinct from genetic risk for amyloid deposition

Leonenko, Ganna ORCID: https://orcid.org/0000-0001-8025-661X, Shoai, Maryam, Bellou, Eftychia, Sims, Rebecca ORCID: https://orcid.org/0000-0002-3885-1199, Williams, Julie ORCID: https://orcid.org/0000-0002-4069-0259, Hardy, John, Escott-Price, Valentina ORCID: https://orcid.org/0000-0003-1784-5483 and the Alzheimer's Disease Neuroimaging Initiative 2019. Genetic risk for Alzheimer's disease is distinct from genetic risk for amyloid deposition. Annals of Neurology 86 (3) , pp. 427-435. 10.1002/ana.25530

[thumbnail of Leonenko_et_al-2019-Annals_of_Neurology.pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (439kB) | Preview
[thumbnail of Table 1]
Preview
PDF (Table 1) - Supplemental Material
Download (121kB) | Preview
[thumbnail of Table 2]
Preview
PDF (Table 2) - Supplemental Material
Download (114kB) | Preview
[thumbnail of Table 3]
Preview
PDF (Table 3) - Supplemental Material
Download (178kB) | Preview
[thumbnail of Table 4]
Preview
PDF (Table 4) - Supplemental Material
Download (159kB) | Preview
[thumbnail of Table 5]
Preview
PDF (Table 5) - Supplemental Material
Download (157kB) | Preview
[thumbnail of PRS histogram]
Preview
Image (TIFF) (PRS histogram) - Supplemental Material
Download (11MB) | Preview
[thumbnail of Figure 2]
Preview
Image (TIFF) (Figure 2) - Supplemental Material
Download (12MB) | Preview

Abstract

Objectives Alzheimer's disease (AD) is the most common form of dementia and is responsible for a huge and growing health care burden in the developed and developing world. The Polygenic Risk Score (PRS) approach has shown 75%‐84% prediction accuracy of identifying individuals with AD risk. Methods In this study we tested the prediction accuracy of AD, MCI and amyloid deposition risks with PRS, including and excluding APOE genotypes in a large publicly available data set with extensive phenotypic data: the Alzheimer's Disease Neuroimaging Initiative cohort. Among MCI individuals with amyloid positive status we examined PRS prediction accuracy in those who converted to AD. In addition, we divided polygenic risk score by biological pathways and tested them independently for distinguishing between AD, MCI and amyloid deposition. Results We found that AD and MCI are predicted by both APOE genotype and PRS (AUC=0.82% and 68%, respectively). Amyloid deposition is predicted by APOE only (AUC=79%). Further progression to AD of individuals with MCI and amyloid positive status is predicted by PRS over and above APOE (AUC=67%).

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Additional Information: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Publisher: Wiley
ISSN: 0364-5134
Funders: MRC
Date of First Compliant Deposit: 18 June 2019
Date of Acceptance: 12 June 2019
Last Modified: 06 Jan 2024 03:40
URI: https://orca.cardiff.ac.uk/id/eprint/123526

Citation Data

Cited 39 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics